Disclaimer: This site aggregates publicly available data from official government sources (FDA, ClinicalTrials.gov, PubMed, SEC EDGAR) for general reference only. It does NOT constitute medical advice, diagnosis, treatment recommendations, or investment advice.

Clinical Trial

Borate-based Bioactive Glass Fiber Matrix (BBGFM) in the Treatment of Venus Leg Ulcers (VLU)

NCT: NCT07647705 · NOT_YET_RECRUITING

NCT IDNCT07647705
StatusNOT_YET_RECRUITING
Start Date2026-07
Completion2028-01
SponsorETS Wound Care, LLC (INDUSTRY)
First posted
Last updated

Brief Summary

The goal of this clinical trial is to learn if Borate-based Bioactive Glass Fiber Matrix (BBGFM) can help heal Venous Leg Ulcers (VLU) that have not closed with standard treatment. The main question it aims to answer is: 1\. Does BBGFM help Venus Leg Ulcers heal completely in 12 weeks? Researchers will compare BBGFM plus Standard of Care (SOC) to SOC alone to see if BBGFM works to heal wounds. Participants will: * Have BBGFM applied to their wound (if assigned to the BBGFM group) for up to 12 applications * Visit the clinic each week for wound checks and tests Other study purposes include looking at: * The time it takes for the wound to heal * Changes in wound size over time * The durability of wound healing after closure * The use of healthcare resources related to wound care * Any adverse events (side effects) or reactions related to the treatment * Changes in pain levels * Changes in quality of life

Frequently Asked Questions

What is Borate-based Bioactive Glass Fiber Matrix (BBGFM) in the Treatment of Venus Leg Ulcers (VLU)?

Borate-based Bioactive Glass Fiber Matrix (BBGFM) in the Treatment of Venus Leg Ulcers (VLU) is a clinical trial registered under NCT07647705. Current status: NOT_YET_RECRUITING.

What is the status of NCT07647705?

The current status of NCT07647705 (Borate-based Bioactive Glass Fiber Matrix (BBGFM) in the Treatment of Venus Leg Ulcers (VLU)) is: NOT_YET_RECRUITING.

When did Borate-based Bioactive Glass Fiber Matrix (BBGFM) in the Treatment of Venus Leg Ulcers (VLU) start?

Borate-based Bioactive Glass Fiber Matrix (BBGFM) in the Treatment of Venus Leg Ulcers (VLU) started on 2026-07.

Related Devices

Official Source

View on ClinicalTrials.gov →

Data sourced from ClinicalTrials.gov API. For the most current status, refer to the official record.